They were monitored for drowsiness and asked to keep their eyes open during TMS. Relaxation of the measured muscle
was controlled by continuous visual EMG monitoring. All participants Ruxolitinib ic50 wore earplugs to protect them from possible acoustic trauma (Rossi et al., 2009), and reduce contamination of TMS-evoked potentials by auditory responses to the clicks produced by the discharge of the TMS coil. The optimal scalp location, over left M1, for TMS-induced activation of the right first FDI was determined as the scalp location from which TMS induced MEPs of maximum peak-to-peak amplitude in the target muscle. Once the optimal spot was identified, the neuronavigation system was used to ensure consistent coil placement and orientation at the optimal spot (Fig. 1A). Resting motor threshold (RMT) was defined as the lowest stimulus intensity of the Nexstim stimulator capable of inducing MEPs of ≥ 50 μV peak-to-peak amplitude in at least five out of ten trials. Active motor threshold (AMT) was defined as the lowest stimulus intensity of the MagPro stimulator capable of inducing visible BMS-734016 twitches
in the FDI in half of the trials while the participants maintained a contraction of the FDI at approximately 20% of the maximal voluntary contraction (Rossini et al., 1994; Chen et al., 2008). Continuous TBS was applied with parameters similar to those used by Huang et al. (2005) – three pulses at 50 Hz, with an interval of 200 ms between the last pulse of a triplet and the first pulse of a triplet, for a total of 600 pulses (Fig. 1B). The intensity was fixed at 80% of AMT. Due to limitations in our experimental set-up, the interstimulus interval was 240 ms compared with the interstimulus interval of 200 ms in the original paradigm introduced by Huang et al. (2005). Thus, in our cTBS paradigm, the triplet repetition rate was about 4.17 Hz instead of 5 Hz, both frequencies being included in the theta band. To establish a pre-cTBS measure, two batches of
10–30 MEPs were recorded in response to a single pulse of TMS at an intensity of 120% of RMT. The pulses were delivered randomly with interstimulus intervals between 5 and 8 s. Following cTBS, a single batch of Methisazone MEPs was measured immediately after (T0) and then at 5, 10, 20, 30, 40, 50 and 60 min following cTBS. EEG was recorded simultaneously at all these times. In a sub-group of seven subjects, resting eyes-closed EEG was recorded at the beginning of the session and after cTBS. These post-cTBS resting EEG measures were recorded sequentially after the single-pulse TMS batches at T5, T10, T20, T30 and T40. Thus, the TX resting EEG measures (X referring to the time in min) started approximately between X + 2 and X + 6 min after cTBS and lasted 2–4 min. Motor-evoked potential peak-to-peak amplitude was determined automatically using the Nexstim Neurophysiologic Analysis software, but checked trial-by-trial by visual inspection.